Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.26M Buy
+43,698
New +$5.04M 0.21% 114
2025
Q2
Sell
-3,255
Closed -$292K 131
2025
Q1
$292K Hold
3,255
0.05% 112
2024
Q4
$324K Sell
3,255
-3,732
-53% -$385K 0.06% 102
2024
Q3
$793K Hold
6,987
0.14% 79
2024
Q2
$865K Buy
6,987
+5,210
+293% +$671K 0.16% 75
2024
Q1
$234K Hold
1,777
0.04% 103
2023
Q4
$194K Sell
1,777
-108
-6% -$11.2K 0.04% 84
2023
Q3
$194K Sell
1,885
-5,028
-73% -$542K 0.04% 89
2023
Q2
$798K Sell
6,913
-8,565
-55% -$972K 0.14% 71
2023
Q1
$1.65M Sell
15,478
-206
-1% -$22.2K 0.24% 72
2022
Q4
$1.74M Buy
15,684
+1,604
+11% +$164K 0.27% 76
2022
Q3
$1.21M Sell
14,080
-2,421
-15% -$216K 0.2% 83
2022
Q2
$1.5M Buy
16,501
+1,726
+12% +$153K 0.21% 72
2022
Q1
$1.21M Sell
14,775
-244
-2% -$19.2K 0.16% 79
2021
Q4
$1.15M Sell
15,019
-22,558
-60% -$1.8M 0.14% 86
2021
Q3
$2.82M Buy
37,577
+3,414
+10% +$260K 0.36% 38
2021
Q2
$2.66M Sell
34,163
-53
-0.2% -$3.94K 0.32% 37
2021
Q1
$2.52M Buy
34,216
+4,918
+17% +$363K 0.3% 41
2020
Q4
$2.29M Buy
29,298
+26,713
+1,033% +$2.04M 0.29% 33
2020
Q3
$205K Sell
2,585
-743
-22% -$58.2K 0.03% 66
2020
Q2
$246K Sell
3,328
-69
-2% -$5.19K 0.06% 51
2020
Q1
$249K Sell
3,397
-1,393
-29% -$109K 0.09% 47
2019
Q4
$416K Buy
4,790
+1,813
+61% +$149K 0.14% 44
2019
Q3
$239K Buy
2,977
+268
+10% +$21.5K 0.03% 61
2019
Q2
$217K Hold
2,709
0.02% 58
2019
Q1
$215K Buy
2,709
+808
+43% +$60.4K 0.12% 42
2018
Q4
$139K Buy
+1,901
New +$134K 0.06% 51

Other funds holding MRK

Mirova's MRK Position: Q1 2026 in Review

Mirova opened a new position in Merck (MRK) in Q1 2026: 43,698 shares worth $5.26M. The stake represents 0.21% of the portfolio and ranks #114 among its holdings. This is a return to the name: Mirova previously reported a position in MRK as recently as Q1 2025.

Mirova first reported a position in MRK in Q4 2018 and has held it in 27 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mirova held 43,698 shares of Merck worth $5.26M as of Q1 2026.
  • Merck was a new Mirova position in Q1 2026.
  • Merck made up 0.21% of Mirova's portfolio in Q1 2026, its #114 holding.
  • Mirova first reported a position in Merck in Q4 2018 and has held it in 27 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mirova's 13F filing for Q1 2026, filed 14 May 2026.